The scientist’s investigation covers issues in Pathology, Cancer research, Internal medicine, Cancer and Breast cancer. Jahn M. Nesland interconnects Cell and Melanoma in the investigation of issues within Pathology. His Cancer research research integrates issues from Cell culture, Cancer stem cell, Molecular biology and Cell cycle, Gene.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. His research investigates the link between Breast cancer and topics such as Survival rate that cross with problems in Adenocarcinoma. The study incorporates disciplines such as Ovarian carcinoma, Breast carcinoma and Survival analysis in addition to Carcinoma.
Jahn M. Nesland mainly focuses on Pathology, Internal medicine, Cancer research, Immunohistochemistry and Oncology. His studies deal with areas such as Ovarian carcinoma and Cancer, Metastasis as well as Pathology. In his research on the topic of Cancer, Hexaminolevulinate and Molecular biology is strongly related with Apoptosis.
His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cell cycle, Carcinogenesis, Tumor suppressor gene and Cancer stem cell. His Immunohistochemistry study integrates concerns from other disciplines, such as Ovary, Stromal cell, Lymph node and Adenocarcinoma. His Oncology research includes elements of Cancer registry, Radiation therapy, Chemotherapy and Univariate analysis.
His primary areas of investigation include Internal medicine, Oncology, Pathology, Cancer research and Cancer. His Internal medicine research includes themes of Endocrinology and Gerontology. His biological study spans a wide range of topics, including Immunohistochemistry, Chemotherapy, Cancer registry, Stage and Cohort.
His Pathology research incorporates elements of Ovarian carcinoma, Cell and Breast cancer. His Cancer research research includes elements of Cell growth, Cancer cell, Apoptosis, Ovarian cancer and Stem cell. The Cancer stem cell research Jahn M. Nesland does as part of his general Cancer study is frequently linked to other disciplines of science, such as DU145, therefore creating a link between diverse domains of science.
His main research concerns Internal medicine, Pathology, Oncology, Cancer research and Cancer. His Internal medicine research is multidisciplinary, incorporating elements of Antibody and Monoclonal antibody. His Pathology research is multidisciplinary, incorporating perspectives in Ovarian carcinoma, Epithelial–mesenchymal transition and Colorectal cancer.
His studies deal with areas such as Immunohistochemistry, Tissue microarray, Prostate cancer, MicroRNA 29c and Cohort as well as Oncology. His Cancer research research incorporates themes from Cell, Cancer cell, Cancer stem cell, Stem cell and Glycolysis. His Cancer research integrates issues from Dysgerminoma, PI3K/AKT/mTOR pathway and Everolimus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jirina Bartkova;Zuzana Ho rcaron;ejší;Karen Koed.
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Qian Peng;Trond Warloe;Kristian Berg;Johan Moan.
5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research
Qian Peng;Kristian Berg;Johan Moan;Magne Kongshaug.
Photochemistry and Photobiology (1997)
Morphologic reappraisal of serrated colorectal polyps.
Emina Torlakovic;Eva Skovlund;Dale C Snover;Goran Torlakovic.
The American Journal of Surgical Pathology (2003)
Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
Sivan Elloul;Mari Bukholt Elstrand;Jahn M. Nesland M.D.;Claes G. Tropé M.D..
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
Hongjuan Zhao;Anita Langerød;Youngran Ji;Kent W. Nowels.
Molecular Biology of the Cell (2004)
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
Vera M Abeler;Odd Røyne;Steinar Thoresen;Håvard E Danielsen.
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Anita Langerød;Hongjuan Zhao;Ørnulf Borgan;Jahn M. Nesland;Jahn M. Nesland.
Breast Cancer Research (2007)
EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival
Zhenhe Suo;Bjørn Risberg;Mats G. Kalsson;Kenneth Willman.
The Journal of Pathology (2002)
Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Qian Peng;Ana Maria Soler;Trond Warloe;Jahn M. Nesland.
Journal of Photochemistry and Photobiology B-biology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: